SCHEMBL420435

SCHEMBL420435

[O]C(F)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6959142 0.77 CES2 (0.42)
SCHEMBL358294 0.75
SCHEMBL6203891 0.75
SCHEMBL4276631 0.73 CES2 (0.50)
SCHEMBL60955 0.73
SCHEMBL41570 0.73 CES2 (0.50)
SCHEMBL915178 0.73 DPP4 (0.47)
SCHEMBL1193669 0.73 DPP4 (0.47)
SCHEMBL2050459 0.73
SCHEMBL6204475 0.73 IDO1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110612285-B Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2023-04-04 CN claimed
US-20220378816-A1 2-BENZYLIDENE HYDRAZINOADENOSINE COMPOUNDS HAVING A2A ADENOSINE RECEPTOR AGONISTIC ACTIVITY ACADEMY OF MILITARY MEDICAL SCIENCES (CN) 2022-12-01 US claimed
EP-3988560-A1 SMALL-MOLECULE COMPOUND HAVING A2A ADENOSINE RECEPTOR ANTAGONISM Academy Of Military Medical Sciences (CN) 2022-04-27 EP claimed
EP-3988559-A1 2-BENZYLIDENE HYDRAZINOADENOSINE COMPOUNDS HAVING A2A ADENOSINE RECEPTOR AGNOSTIC ACTIVITY Academy Of Military Medical Sciences (CN) 2022-04-27 EP claimed
CN-114096551-A Having a2A2-benzylidene hydrazino adenosine compounds with adenosine receptor agonist activity 中国人民解放军军事科学院军事医学研究院 2022-02-25 CN claimed
CN-114096552-A Having a2ASmall molecule compounds with adenosine receptor antagonistic effect 中国人民解放军军事科学院军事医学研究院 2022-02-25 CN claimed
US-20220048892-A1 HETEROCYCLIC DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS RAQUALIA PHARMA INC. (JP) 2022-02-17 US claimed
EP-3902544-A1 HETEROCYCLIC DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS RaQualia Pharma Inc. (JP) 2021-11-03 EP claimed
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers RAQUALIA PHARMA INC. (JP) 2021-10-26 US claimed
CN-113164461-A Heterocyclic derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2021-07-23 CN claimed
EP-0912559-A1 FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 1999-05-06 EP claimed
WO-1998002438-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 1998-01-22 WO claimed
WO-1998002437-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 1998-01-22 WO claimed
WO-1998002434-A1 FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 1998-01-22 WO claimed
EP-0533781-A1 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVES AND ANALOGS AS HYPOGLYCEMIC AGENTS. PFIZER (US) 1993-03-31 EP claimed
WO-1991019702-A1 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVES AND ANALOGS AS HYPOGLYCEMIC AGENTS PFIZER INC. (US) 1991-12-26 WO claimed
US-4956366-A GASTROINTESTINAL DISORDERS, ANTISECRETORY AGENTS FOR GASTRIC ACID SECRETION HOECHST AKTIENGESELLSCHAFT (DE) 1990-09-11 US claimed
EP-0299389-A2 Substituted thieno-imidazole derivatives, process for their preparation, pharmaceutical compositions containing them and their use as gastric secretion inhibitors, gastric protecting agents and as medicaments against intestinal inflammation HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-18 EP claimed
EP-0048548-B1 PHARMACEUTICAL COMPOSITIONS OF FUNGICIDAL TRIAZOLE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-11-14 EP claimed
EP-0048548-A1 Pharmaceutical compositions of fungicidal triazole derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-03-31 EP claimed